Over the past week, the Biden administration has further increased the supply of COVID-19 vaccines, but harsh winter conditions have led to widespread delays in vaccine shipments and deliveries. Additionally, the administration announced plans to invest in domestic manufacturing of testing supplies. Please see details of these and other supplyRead More →

Six women in Congress are calling on federal regulators to take action to remove phthalates and other hormone-diverting chemicals from medical products, especially IV bags and newborn equipment. The United States has made “minimal progress” in reducing harmful exposures to the United States over the past 20 years, even asRead More →

Insightec is strategically positioned for expansion in the China Marlet HAIFA, Israel and MIAMI, February 10, 2021 / PRNewswire / – Insightec®, a global healthcare company focused on creating the next generation of patient care, announced that it has received marketing approval from the National Medical Products Administration (NMPA), China’sRead More →

As the public health agency responsible for regulating medical products, we need to ensure that healthcare providers have the latest diagnostics, treatments and vaccines in their toolkit to tackle this pandemic. We understand the need to adapt and pivot to support the modification or development of these lifesaving tools asRead More →